These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32033361)

  • 21. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population.
    Lim A; Sharma P; Stepanov O; Reddy VP
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges of Vancomycin Dosing and Therapeutic Monitoring in Neonates.
    Pham JT
    J Pediatr Pharmacol Ther; 2020; 25(6):476-484. PubMed ID: 32839651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures.
    Tulloch JK; Carr RR; Ensom MH
    J Pediatr Pharmacol Ther; 2012 Jan; 17(1):31-44. PubMed ID: 23118657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studies.
    Gidal BE; Majid O; Ferry J; Hussein Z; Yang H; Zhu J; Fain R; Laurenza A
    Epilepsy Behav; 2014 Jun; 35():6-12. PubMed ID: 24785428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates.
    Smits A; Annaert P; Van Cruchten S; Allegaert K
    Front Pharmacol; 2020; 11():587. PubMed ID: 32477113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.
    Baer GR; Nelson RM;
    Clin Ther; 2006 Sep; 28(9):1399-407. PubMed ID: 17062312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
    Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
    Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informed Consent in Health Research: Challenges and Barriers in Low-and Middle-Income Countries with Specific Reference to Nepal.
    Regmi PR; Aryal N; Kurmi O; Pant PR; van Teijlingen E; Wasti SP
    Dev World Bioeth; 2017 Aug; 17(2):84-89. PubMed ID: 27518590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders' Perspectives: Systematic Review.
    De Sutter E; Zaçe D; Boccia S; Di Pietro ML; Geerts D; Borry P; Huys I
    J Med Internet Res; 2020 Oct; 22(10):e19129. PubMed ID: 33030440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical issues in research to improve the management of malignant bowel obstruction: challenges and recommendations.
    Laneader A; Angelos P; Ferrell BR; Kolker A; Miner T; Padilla G; Swaney J; Krouse RS; Casarett D
    J Pain Symptom Manage; 2007 Jul; 34(1 Suppl):S20-7. PubMed ID: 17532176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethics of drug research in the pediatric intensive care unit.
    Kleiber N; Tromp K; Mooij MG; van de Vathorst S; Tibboel D; de Wildt SN
    Paediatr Drugs; 2015 Feb; 17(1):43-53. PubMed ID: 25354987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.
    Ng CM; Dombrowsky E; Lin H; Erlich ME; Moody DE; Barrett JS; Kraft WK
    Pharmacotherapy; 2015 Jul; 35(7):670-80. PubMed ID: 26172282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.
    Frymoyer A; Stockmann C; Hersh AL; Goswami S; Keizer RJ
    J Pediatric Infect Dis Soc; 2019 May; 8(2):97-104. PubMed ID: 29294072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.
    Janssen EJ; Välitalo PA; Allegaert K; de Cock RF; Simons SH; Sherwin CM; Mouton JW; van den Anker JN; Knibbe CA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1013-21. PubMed ID: 26643337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic Model.
    Völler S; Flint RB; Beggah F; Reiss I; Andriessen P; Zimmermann LJI; van den Anker JN; Liem KD; Koch BCP; de Wildt S; Knibbe CAJ; Simons SHP
    J Clin Pharmacol; 2019 Oct; 59(10):1300-1308. PubMed ID: 31093992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.
    Stockmann C; Hersh AL; Roberts JK; Bhongsatiern J; Korgenski EK; Spigarelli MG; Sherwin CM; Frymoyer A
    Infect Dis Ther; 2015 Jun; 4(2):187-98. PubMed ID: 25998107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.